CT Pancreas Perfusion
This study has been completed.
Information provided by:
First received: December 24, 2007
Last updated: March 21, 2011
Last verified: March 2011
- Pancreatic CT perfusion with a biofeedback breathing belt worn by the participant, and using novel post-processing techniques, is a reliable method which can be used to differentiate between pancreatic cancer, chronic pancreatitis, and autoimmune pancreatitis.
- Pancreatic CT perfusion can be used to monitor patients undergoing decompression treatment (endoscopic retrograde cholangiopancreatography with stent placement) for painful chronic pancreatitis, and the change in the pancreatic perfusion parameters correlate with the change in the pain parameters (pain scale and analgesic use).
- Pancreatic CT perfusion parameters can be calculated using surrogate scan data sets at specific time points to replace the continuous scanning.
Pancreatic Ductal Adenocarcinoma
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||CT Perfusion of Pancreatic Cancer and Chronic Pancreatitis: Feasibility Study|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Mayo Clinic:
Primary Outcome Measures:
- A reproducible technique to measure CT perfusion parameters may provide a method for non-invasively monitoring tumor response during treatment, or differentiating between autoimmune and chronic pancreatitis. [ Time Frame: Three weeks to three months for chronic pancreatitis. ] [ Designated as safety issue: No ]
|Study Start Date:||April 2006|
|Study Completion Date:||February 2009|
|Primary Completion Date:||February 2009 (Final data collection date for primary outcome measure)|
Suspected pancreatic ductal adenocarcinoma.
Chronic pancreatitis and slated for decompression treatment.
Contacts and Locations